Catalyst Wire Dossier Catalyst Wire Dossier

AGB101

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for AGB101, covering 2024-05-17 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial Evaluating the Efficacy of AGB101 for Reducing Hippocampal Overactivity in Older Adults [Phase 2]

See pricing